← Back
$VIR All transactions

Vir Biotechnology, Inc.

▼ SELL 10b5-1 Plan

$ Value

$12K

Shares

2,385

Price

$5

Filed

Nov 7

Insider

Name

de Verneuil Vanina

Title

EVP, General Counsel, Corp Sec

CIK

0002036234

Roles

Officer

Transaction Details

Transaction Date

2025-11-05

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

78,210

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 5, 2024.

Filing Info

Accession No.

0001628280-25-050592

Form Type

4

Issuer CIK

0001706431

de Verneuil Vanina's History

Date Ticker Type Value
2026-02-25 VIR $135K
2026-02-24 VIR $30K
2026-02-23 VIR $33K
2026-02-22 VIR A $0
2026-02-22 VIR A $0
2025-11-05 VIR $12K
2025-11-03 VIR $8K

Other Insiders at VIR (90d)

Insider Bought Sold Last
SATO VICKI L $992K 2026-04-01
De Backer Marianne
Chief Executive Officer
$283K 2026-02-24
De Backer Marianne
President and CEO
$664K 2026-04-06
Eisner Mark
EVP and Chief Medical Officer
$50K 2026-02-25
O'Byrne Jason
EVP & Chief Financial Officer
$31K 2026-02-24
de Verneuil Vanina
EVP, General Counsel, Corp Sec
$197K 2026-02-25
Sabatini Brent
SVP, Chief Accounting Officer
$110K 2026-03-23